title: A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
abstract: To further characterise the genetic background of the two closely related B-lymphocytic malignancies hairy cell leukaemia (HCL), and splenic marginal zone lymphoma (SMZL) we have identified characteristic copy number imbalances by comparative genomic hybridisation (CGH). Based on these findings, areas of special interest were fine mapped, and relevant probes constructed for use in interphase-fluorescence in situ hybridisation (FISH) investigations. Thus, using the CGH data from 52 HCL and 61 SMZL patients, we identified the characteristic profiles of copy number imbalances for both diseases. These were a gain of 5q13-31 (19%) and loss of 7q22-q35 (6%) for HCL, and gain of 3q25 (28%), loss of 7q31 (16%), and gain of 12q15 (16%) for SMZL. A partial loss of 7q unusual for low-malignant B-cell diseases was found to be common to the two diseases. This loss was therefore fine mapped with BAC/PAC clones. Fine mapping revealed that in SMZL the minimal lost region covers 11.4 Mb spanning from 7q31.33 to 7q33 located between sequence tagged site (STS)-markers SHGC-3275 and D7S725. This area was distinct from the commonly deleted 7q region of myelodysplastic syndrome/acute myeloid leukaemia (MDS/AML). A FISH probe specific for the 7q region was constructed. Using this probe in an interphase-FISH investigation we showed the minimal lost 7q-region of HCL and SMZL to be one and the same. In one HCL case, this investigation furthermore showed the extent of the deleted region to be below the detection limit of CGH, whereas interphase-FISH screening of 36 chronic lymphocytic leukaemia (CLL) cases showed no deletion of the 7q area. In conclusion, we have identified characteristic profiles of copy number imbalances in HCL and SMZL and fine mapped the minimal extent of a commonly lost 7q area of special interest. We hypothesise that this region may contain (a) gene(s) important for the pathology of HCL and SMZL.
authors.affiliation: Laboratory of Cancercytogenetics, Department of Hematology, Aarhus Amtssygehus, Aarhus University Hospital, Aarhus C, Denmark.
authors.forename: Claus Lindbjerg
authors.initials: CL
authors.lastname: Andersen
authors.forename: Alicja
authors.initials: A
authors.lastname: Gruszka-Westwood
authors.forename: Mette
authors.initials: M
authors.lastname: Østergaard
authors.forename: Jørn
authors.initials: J
authors.lastname: Koch
authors.forename: Elisa
authors.initials: E
authors.lastname: Jacobsen
authors.forename: Eigil
authors.initials: E
authors.lastname: Kjeldsen
authors.forename: Bendt
authors.initials: B
authors.lastname: Nielsen
mesh_terms: D001706:Biopsy; D045744:Cell Line, Tumor; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D002897:Chromosomes, Human, Pair 7; D004273:DNA, Neoplasm / Q000235:genetics; D018628:Gene Dosage; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007943:Leukemia, Hairy Cell / Q000453:epidemiology / Q000235:genetics*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000453:epidemiology / Q000235:genetics*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000453:epidemiology / Q000235:genetics*; D017720:Molecular Epidemiology; D013160:Splenic Neoplasms / Q000453:epidemiology / Q000235:genetics*
chemical_list: D004273:DNA, Neoplasm